Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
TD Cowen Reiterates Buy on Establishment Labs Hldgs, Maintains $117 Price Target
Establishment Labs Extends Master Supply Agreement With NuSil Technology To December 31, 2031
Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Establishment Labs: Procedure Economics Strengthens The Bull Case
BTIG Reiterates Buy on Establishment Labs Hldgs, Maintains $103 Price Target
Citigroup Upgrades Establishment Labs Hldgs to Buy, Maintains Price Target to $92
Baron Discovery Fund’s Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks Gains
Establishment Labs (ESTA) Stock Looks Fair On Cash Flow Yet Trades At A Premium On Sales
JP Morgan Maintains Overweight on Establishment Labs Hldgs, Raises Price Target to $95
Establishment Labs Holdings Inc (ESTA) (Q2 2026) Earnings Call Highlights: U.S. Sales Surge 140. ...
Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript
Establishment Labs Q2 Earnings Call Highlights
Needham Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $95
BTIG Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $103
Establishment Labs® Reports Second Quarter 2026 Financial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.